stockportfolio.pro
Charles River Laboratories International, Inc. Total Debt 2008–2025
Charles River Laboratories International, Inc. (CRL) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $0 | — |
| FY 2024 | $0 | — |
| FY 2023 | $0 | — |
| FY 2022 | $0 | — |
| FY 2021 | $0 | — |
| FY 2020 | $0 | — |
| FY 2019 | $0 | -100.0% |
| FY 2018 | $1.61B | +48.3% |
| FY 2017 | $1.09B | -8.0% |
| FY 2016 | $1.18B | +45.0% |
| FY 2015 | $814.24M | +13.6% |
| FY 2014 | $716.63M | +8.1% |
| FY 2013 | $663.05M | -0.5% |
| FY 2012 | $666.45M | -7.2% |
| FY 2011 | $717.90M | +2.4% |
| FY 2010 | $700.75M | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
Source: Charles River Laboratories International, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Charles River Laboratories International, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories International, Inc. — frequently asked questions
What is Charles River Laboratories International, Inc.'s total debt (short- plus long-term borrowings)?
Charles River Laboratories International, Inc. (CRL) reported total debt (short- plus long-term borrowings) of $0 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Charles River Laboratories International, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.